1. Abosch A, Kapur S, Lang A, Hussey D, Sime E, Miyasaki J, et al. Stimulation of the subthalamic nucleus in Parkinson’s disease does not produce striatal dopamine release. Neurosurgery. 53:1095–1102. 2003.
Article
2. Bar Gad I, Elias S, Vaadia E, Bergman H. Complex locking rather than complete cessation of neuronal activity in the globus pallidus of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primate in response to pallidal microstimulation. J Neurosci. 24:7410–7419. 2004.
Article
3. Bruet N, Windels F, Carcenac C, Feuerstein C, Bertrand A, Poupard A, et al. Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats. J Neuropathol Exp Neurol. 62:1228–1240. 2003.
Article
4. Carman LS, Gage FH, Shults CW. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 553:275–283. 1991.
Article
5. Chevalier G, Deniau JM. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci. 13:277–280. 1990.
Article
6. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:281–285. 1990.
Article
7. Deumens R, Blokland A, Prickaerts J. Modeling Parkinson’s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol. 175:303–317. 2002.
Article
8. Henning J, Koczan D, Glass A, Karopka T, Pahnke J, Rolfs A, et al. Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression. Eur J Neurosci. 25:239–250. 2007.
Article
9. Hodaie M, Wennberg R, Dostrovsky J, Lozano A. Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia. 43:603–608. 2002.
Article
10. Krack P, Batir A, Van Blercom Ng, Chabardes S, Fraix Vr, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 349:1925–1934. 2003.
Article
11. Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson’s disease. Lancet. 350:1675. 1997.
Article
12. Lacombe E, Carcenac C, Boulet S, Feuerstein C, Bertrand A, Poupard A, et al. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats. Eur J Neurosci. 26:1670–1680. 2007.
Article
13. Lang AE, Widner H. Deep brain stimulation for Parkinson’s disease: patient selection and evaluation. Mov Disord. 17(Suppl 3):S94–S101. 2002.
Article
14. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Broussolle E, Perret JE, et al. Bilateral subthalamic nucleus stimulation for severe Parkinson’s disease. Mov Disord. 10:672–674. 1995.
Article
15. McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol. 115:1239–1248. 2004.
Article
16. Megías M, Emri Z, Freund TF, Gulyás AI. Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience. 102:527–540. 2001.
Article
17. Meissner W, Harnack D, Reese R, Paul G, Reum T, Ansorge M, et al. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. J Neurochem. 85:601–609. 2003.
Article
18. Nambu A. A new approach to understand the pathophysiology of Parkinson’s disease. J Neurol. 252(Suppl 4):IV1–IV4. 2005.
Article
19. Papa SM, Engber TM, Kask AM, Chase TN. Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration. Brain Res. 662:69–74. 1994.
Article
20. Paxinos G. The rat nervous system. Amsterdam ; Boston: Elsevier Academic Press;2004.
21. Pollak P, Benabid AL, Gross C, Gao DM, Laurent A, Benazzouz A, et al. Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev Neurol (Paris). 149:175–176. 1993.
22. Segovia G, Del Arco A, Mora F. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study. J Neurochem. 69:1476–1483. 1997.
Article
23. Shipton EA. Movement disorders and neuromodulation. Neurol Res Int. 2012:309431. 2012.
Article
24. Visser-Vandewalle V, van der Linden C, Temel Y, Celik H, Ackermans L, Spincemaille G, et al. Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat Disord. 11:157–165. 2005.
Article
25. Wichmann T, Delong MR. Deep-brain stimulation for basal ganglia disorders. Basal Ganglia. 1:65–77. 2011.
Article
26. Wichmann T, DeLong MR, Guridi J, Obeso JA. Milestones in research on the pathophysiology of Parkinson’s disease. Mov Disord. 26:1032–1041. 2011.
Article
27. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 132:645–660. 2008.
Article